Johnson & Johnson (JNJ) Return on Capital Employed (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Return on Capital Employed came in at 28.18% in Q1 2026, up 1180.0% year-on-year from 2.2% in Q1 2025, and little changed quarter-over-quarter from 28.14% in Q4 2025.

Johnson & Johnson (JNJ) Return on Capital Employed (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Return on Capital Employed across 18 years of filings, most recently posting 28.18% for Q1 2026.

  • Return on Capital Employed for Q1 2026 came in at 28.18%, up 1180.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 28.18% (up 1180.0% YoY), and the FY2025 annual result was 29.46%, up 1244.0% from the prior year.
  • Return on Capital Employed came in at 28.18% for Q1 2026 at Johnson & Johnson, roughly flat from 28.14% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 30.16% in Q2 2024 to a low of 15.38% in Q4 2022.
  • The 5-year median for Return on Capital Employed is 18.66% (2023), against an average of 21.41%.
  • Peak annual rise in Return on Capital Employed reached 1183 bps in 2025, while the deepest fall reached 1476 bps in 2025.
  • Johnson & Johnson's Return on Capital Employed stood at 15.38% in 2022, then surged by 95 bps to 29.97% in 2023, then tumbled by 46 bps to 16.31% in 2024, then surged by 73 bps to 28.14% in 2025, then increased by 0 bps to 28.18% in 2026.
  • The last three Return on Capital Employed figures came in at 28.18% (Q1 2026), 28.14% (Q4 2025), and 16.49% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Gsk 96,436,181.12 Bn 96,436,176.16 Bn 7.76 Bn 9.49%
2 Eli Lilly 1,017.30 Bn 1,012.01 Bn 16.22 Bn 42.94%
3 Johnson & Johnson 579.61 Bn 557.55 Bn 15.96 Bn 28.18%
4 AbbVie 402.30 Bn 392.96 Bn 10.78 Bn 16.47%
5 Merck 294.24 Bn 288.59 Bn 12.09 Bn -5.22%
6 Amgen 191.82 Bn 179.78 Bn 5.87 Bn 15.87%
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn 21.53%
8 Pfizer 149.05 Bn 136.28 Bn -1.21 Bn -10.20%
9 Bristol Myers Squibb 116.33 Bn 105.88 Bn 8.07 Bn -6.84%
10 Novartis Ag 112.59 Bn 111.90 Bn - -

Historic Data

Download Data
DateValue
Mar 29, 2026 28.18%
Dec 28, 2025 28.14%
Sep 28, 2025 16.49%
Jun 29, 2025 15.40%
Mar 30, 2025 16.38%
Dec 29, 2024 16.31%
Sep 29, 2024 28.35%
Jun 30, 2024 30.16%
Mar 31, 2024 30.00%
Dec 31, 2023 29.97%
Oct 1, 2023 19.98%
Jul 2, 2023 18.93%
Apr 2, 2023 18.66%
Jan 1, 2023 18.44%
Oct 2, 2022 15.38%
Jul 3, 2022 15.79%
Apr 3, 2022 17.37%
Oct 3, 2021 20.67%
Jul 4, 2021 19.67%
Apr 4, 2021 18.45%